{
    "clinical_study": {
        "@rank": "109267", 
        "arm_group": [
            {
                "arm_group_label": "Acetyl-L-carnitine", 
                "arm_group_type": "Experimental", 
                "description": "2 g daily for 12 months"
            }, 
            {
                "arm_group_label": "placebo", 
                "arm_group_type": "Placebo Comparator"
            }
        ], 
        "brief_summary": {
            "textblock": "To assess the effects of Acetyl-L-Carnitine administration on work productivity, daily\n      activity, and fatigue in subjects with chronic hepatitis C treated with\n      Pegylated-Interferon-\u03b12b and Ribavirin."
        }, 
        "brief_title": "Acetyl-L-Carnitine Supplementation During HCV Therapy With Pegylated Interferon-\u03b12b Plus Ribavirin", 
        "completion_date": {
            "#text": "October 1997", 
            "@type": "Actual"
        }, 
        "condition": [
            "Work Productivity and Activity Impairment in Workers With Chronic C Hepatitis", 
            "Fatigue in Workers With Chronic C Hepatitis", 
            "Fatigue"
        ], 
        "condition_browse": {
            "mesh_term": [
                "Fatigue", 
                "Hepatitis", 
                "Hepatitis A"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  workers who were 18 years of age or older\n\n          -  Workers who were infected by HCV and had a quantifiable serum HCV RNA level (as\n             determined by polimerase chain reaction, COBAS AmpliPrep/COBAS TaqMan - ROCHE)\n\n          -  Cirrhotic workers with a Child-Pugh score less than 7\n\n        Exclusion Criteria:\n\n          -  workers who had other liver diseases\n\n          -  cancer\n\n          -  severe jaundice\n\n          -  pulmonary and renal chronic diseases,\n\n          -  prostatic diseases\n\n          -  autoimmune diseases\n\n          -  diabetes mellitus\n\n          -  decompensated cirrhosis\n\n          -  pregnancy\n\n          -  cardiopathy\n\n          -  hemoglobinopathies\n\n          -  hemocromatosis\n\n          -  major depression\n\n          -  severe psychiatric pathological conditions"
            }, 
            "gender": "Both", 
            "healthy_volunteers": "Accepts Healthy Volunteers", 
            "maximum_age": "65 Years", 
            "minimum_age": "45 Years"
        }, 
        "firstreceived_date": "July 26, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01913964", 
            "org_study_id": "10/1997"
        }, 
        "intervention": [
            {
                "arm_group_label": "Acetyl-L-carnitine", 
                "intervention_name": "Acetylcarnitine", 
                "intervention_type": "Drug"
            }, 
            {
                "arm_group_label": "placebo", 
                "description": "(sugar pill)", 
                "intervention_name": "Placebo", 
                "intervention_type": "Drug"
            }
        ], 
        "intervention_browse": {
            "mesh_term": "Acetylcarnitine"
        }, 
        "is_fda_regulated": "No", 
        "lastchanged_date": "July 31, 2013", 
        "number_of_arms": "2", 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "Italy: Ethics Committee", 
            "has_dmc": "Yes"
        }, 
        "phase": "Phase 4", 
        "primary_completion_date": {
            "#text": "October 1997", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "Work productivity loss, impairment in daily activities, presenteeism, absenteeism, will be assessed using the Work Productivity and Activity Impairment questionnaire.", 
            "measure": "Work Productivity and Activity Impairment in workers with chronic hepatitis C", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01913964"
        }, 
        "responsible_party": {
            "investigator_affiliation": "University of Catania", 
            "investigator_full_name": "Mariano Malaguarnera", 
            "investigator_title": "Associate Professor", 
            "responsible_party_type": "Principal Investigator"
        }, 
        "secondary_outcome": {
            "description": "Severity of fatigue, mental fatigue and physical fatigue.", 
            "measure": "Fatigue in workers with chronic hepatitis C", 
            "safety_issue": "No", 
            "time_frame": "12 months"
        }, 
        "source": "University of Catania", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "University of Catania", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "October 1997", 
        "study_design": "Allocation: Randomized, Endpoint Classification: Safety/Efficacy Study, Intervention Model: Parallel Assignment, Masking: Double Blind (Subject, Investigator), Primary Purpose: Treatment", 
        "study_type": "Interventional", 
        "verification_date": "July 2013"
    }
}